Search

Home > JACC Podcast > Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
Podcast: JACC Podcast
Episode:

Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
Category: Health
Duration: 00:11:30
Publish Date: 2024-11-04 15:00:00
Description:

In this episode, Dr. Valentin Fuster discusses groundbreaking research on SGLT2 inhibitors and their impact on heart failure, highlighting the validation of mechanistic proteomic signatures from a major clinical trial. The study reveals how empagliflozin influences over 2,000 proteins, promoting autophagy, enhancing mitochondrial health, and normalizing kidney function, offering new insights into therapeutic strategies for heart failure management.
Total Play: 0

Some more Podcasts by American College of Cardiology

500+ Episodes
JACC: Clinic .. 10+     1
1K+ Episodes
JACC's Audio .. 70+     10+